Wed, Mar 5, 9:58 AM, Zacks
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog
Last week saw companies like Medivation, Arena and VIVUS reporting fourth quarter results. But, the spotlight remained on InterMune with its late-stage data on Esbriet.
Wed, Feb 26, 3:45 PM, Zacks
InterMune Soars on Positive Esbriet Data - Analyst Blog
InterMune shares escalated a massive 170.8% and also touched a 52-week high on Esbriet Data.